NYP Advances vs MCSAID

NYP Advances brings together the latest updates in heart failure with expert reviews of clinical trials that have shaped the field, our state-of-the-art heart failure conference series, as well as insight into ongoing heart failure research at NYP, all available at your fingertips. Stay up-to-date on breakthroughs in the treatment of heart failure through the innovative work being led by the teams at NewYork-Presbyterian, with world-class doctors from Columbia and Weill Cornell Medicine. NewYork-Presbyterian is a top hospital per U.S. News & World Report (2024-2025).

MCSAID is an educational application dedicated to the topic of mechanical cardiocirculatory support for patients with cardiogenic shock. A basic section introduces the definitions and classifications of cardiogenic shock as well as some of the common devices used for hemodynamic support in unstable patients. There is an algorithm for helping understand the decision process depending on key clinical variables such as cardiac output and PAPI. There are also several weaning and escalation algorithm. A calculator section is available for some common hemodynamic variables used in MCS decision-making and is available for quick-reference throughout the algorithm. MCSAID is an educational application for medical professionals and is not intended for making medical diagnoses. Medical decisions must be made by licensed professionals with the entire context of a patient’s medical history. If you are seeking a medical diagnosis, contact your physician and if you are experiencing a medical emergency, call your local emergency medical services.